According to Spectrum Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$0.36. In 2022 the company made an earnings per share (EPS) of -$0.43 an increase over its 2021 EPS that were of -$1.04.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.36 | -16.28% |
2022 | -$0.43 | -58.65% |
2021 | -$1.04 | -20% |
2020 | -$1.30 | 27.45% |
2019 | -$1.02 | -12.07% |
2018 | -$1.16 | 7.41% |
2017 | -$1.08 | 16.13% |
2016 | -$0.93 | 20.78% |
2015 | -$0.77 | 5.48% |
2014 | -$0.73 | -27.72% |
2013 | -$1.01 | -162.28% |
2012 | $1.62 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $14.09 | -4,012.58% | ๐บ๐ธ USA |
Novartis NVS | $3.74 | -1,138.89% | ๐จ๐ญ Switzerland |
Pfizer PFE | $1.86 | -616.67% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $2.97 | -925.61% | ๐บ๐ธ USA |
Biogen BIIB | $18.46 | -5,227.78% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $3.97 | -1,202.78% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $3.50 | -1,072.42% | ๐ฌ๐ง UK |
Seagen
SGEN | -$4.01 | 1,013.89% | ๐บ๐ธ USA |
Curis CRIS | -$10.00 | 2,677.78% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | -$2.00 | 455.56% | ๐ฎ๐ฑ Israel |